LAUREN ALVAREZ: Open Payments
NPI 1114579893 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,828 in 86 payments from 22 companies in 2025. Trend: 2023 $1,675 · 2024 $1,152 · 2025 $1,828
Food & beverage: $1,828
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 21 | $355 |
| Alnylam Pharmaceuticals Inc. | 12 | $221 |
| SK Life Science, Inc. | 13 | $220 |
| ARGENX US, INC. | 8 | $164 |
| Teva Pharmaceuticals USA, Inc. | 3 | $153 |
| Alexion Pharmaceuticals, Inc. | 5 | $116 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Grifols USA, LLC | 2 | $65 |
| Biogen, Inc. | 3 | $59 |
| Lundbeck LLC | 2 | $58 |
Products named: AMVUTTRA, Briviact, VYVGART HYTRULO, AUSTEDO XR, Nayzilam, ULTOMIRIS, REXULTI, Gamunex-C.
Industry payments across NY — which companies pay providers there.
